Virtu Financial’s Sophiris Bio, Inc. SPHS Stock Holding History

Virtu Financial’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$21K	Sell	57,195 -2,274	-4%	-$1.03K	﹤0.01%	1321
2019 Q3	$35K	Buy	+59,469	New	+$52.8K	﹤0.01%	1242
2019 Q2	–	Sell	-24,234	Closed	-$24K	–	2116
2019 Q1	$24K	Sell	24,234 -11,585	-32%	-$12.4K	﹤0.01%	1272
2018 Q4	$30K	Buy	+35,819	New	+$70.5K	﹤0.01%	1337
2018 Q2	–	Sell	-33,712	Closed	-$68K	–	2855
2018 Q1	$68K	Sell	33,712 -136,078	-80%	-$295K	﹤0.01%	1653
2017 Q4	$385K	Buy	169,790 +135,119	+390%	+$294K	0.02%	1054
2017 Q3	$74K	Buy	+34,671	New	+$71.8K	﹤0.01%	2149

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Virtu Financial's SPHS Position: Q4 2019 in Review

Virtu Financial reduced its Sophiris Bio, Inc. (SPHS) stake by 3.8% in Q4 2019, selling an estimated $1.03K and leaving 57,195 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Virtu Financial first reported a position in SPHS in Q3 2017 and has held it in 7 quarters since. The position peaked at $385K in Q4 2017. 27 funds tracked by Wall St. Rank hold SPHS as of Q4 2019.

Virtu Financial held 57,195 shares of Sophiris Bio, Inc. worth $21K as of Q4 2019.
Virtu Financial sold 2,274 Sophiris Bio, Inc. shares in Q4 2019, an estimated $1.03K.
Sophiris Bio, Inc. made up ﹤0.01% of Virtu Financial's portfolio in Q4 2019, its #1321 holding.
Virtu Financial first reported a position in Sophiris Bio, Inc. in Q3 2017 and has held it in 7 quarters since.
Virtu Financial's Sophiris Bio, Inc. position peaked at $385K in Q4 2017.
27 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.